{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T01:36:42Z","timestamp":1792719402118,"version":"4.5.0"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","drugandalcoholdependence.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.drugalcdep.2015.04.022","type":"journal-article","created":{"date-parts":[[2015,5,8]],"date-time":"2015-05-08T12:23:40Z","timestamp":1431087820000},"page":"57-61","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Serum level of vascular endothelial growth factor decreased in chronic ketamine abusers"],"prefix":"10.1016","volume":"152","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3007-3174","authenticated-orcid":false,"given":"Ni","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyin","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuping","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefeng","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbo","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2015.04.022_bib0005","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s00213-005-0092-6","article-title":"Cortical glutamate\u2013dopamine interaction and ketamine-induced psychotic symptoms in man","volume":"182","author":"Aalto","year":"2005","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.drugalcdep.2015.04.022_bib0010","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1159\/000395074","article-title":"Assessment of depression: the depression inventory","volume":"7","author":"Beck","year":"1974","journal-title":"Mod. Probl. Pharmacopsychiatry"},{"key":"10.1016\/j.drugalcdep.2015.04.022_bib0015","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1037\/0022-006X.56.6.893","article-title":"An inventory for measuring clinical anxiety: psychometric properties","volume":"56","author":"Beck","year":"1988","journal-title":"J. Consult. Clin. Psychol."},{"key":"10.1016\/j.drugalcdep.2015.04.022_bib0020","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0278-5846(03)00080-0","article-title":"Ketamine-induced changes in rat behaviour: a possible animal model of schizophrenia","volume":"27","author":"Becker","year":"2003","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2015.04.022_bib0025","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","article-title":"Antidepressant effects of ketamine in depressed patients","volume":"47","author":"Berman","year":"2000","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2015.04.022_bib0030","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1365-2990.2004.00600.x","article-title":"Vascular endothelial growth factor and the nervous system","volume":"30","author":"Brockington","year":"2004","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.drugalcdep.2015.04.022_bib0035","doi-asserted-by":"crossref","first-page":"733","DOI":"10.3109\/02713683.2010.483312","article-title":"Pharmacological inhibition of N-methyl d-aspartate receptor promotes secretion of vascular endothelial growth factor in M\u00fcller cells: effects of hyperglycemia and hypoxia","volume":"35","author":"Cervantes-Villagrana","year":"2010","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.drugalcdep.2015.04.022_bib0040","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.clinbiochem.2009.10.005","article-title":"Serum levels of vascular endothelial growth factor and its receptors in patients with severe autism","volume":"43","author":"Emanuele","year":"2010","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.drugalcdep.2015.04.022_bib0045","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.schres.2009.06.005","article-title":"Decreased VEGF mRNA expression in the dorsolateral prefrontal cortex of schizophrenia subjects","volume":"115","author":"Fulzele","year":"2009","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.drugalcdep.2015.04.022_bib0050","doi-asserted-by":"crossref","first-page":"e9767","DOI":"10.1371\/journal.pone.0009767","article-title":"Murine neural stem\/progenitor cells protect neurons against ischemia by HIF-1alpha-regulated VEGF signaling","volume":"5","author":"Harms","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.drugalcdep.2015.04.022_bib0055","first-page":"1041","article-title":"Defining the CREB regulon: a genome-wide analysis of transcription factor regulatory regions","volume":"119","author":"Impey","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.drugalcdep.2015.04.022_bib0060","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.neuint.2014.05.009","article-title":"Possible involvement of VEGF signaling system in rescuing effect of endogenous acetylcholine on NMDA-induced long-lasting hippocampal cell damage in organotypic hippocampal slice cultures","volume":"75","author":"Inada","year":"2014","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.drugalcdep.2015.04.022_bib0065","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.drugalcdep.2015.04.022_bib0070","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.drugalcdep.2014.06.043","article-title":"Serum brain-derived neurotrophic factor and nerve growth factor decreased in chronic ketamine abusers","volume":"142","author":"Ke","year":"2014","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2015.04.022_bib0075","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/archpsyc.1994.03950030035004","article-title":"Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans, psychotomimetic, perceptual, cognitive, and neuroendocrine responses","volume":"51","author":"Krystal","year":"1994","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2015.04.022_bib0080","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.bcp.2014.08.008","article-title":"Brain-derived neurotrophic factor increases vascular endothelial growth factor expression and enhances angiogenesis in human chondrosarcoma cells","volume":"91","author":"Lin","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2015.04.022_bib0085","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1111\/j.1360-0443.2004.00879.x","article-title":"Beyond the K-hole: a 3-year longitudinal investigation of the cognitive and subjective effects of ketamine in recreational users who have substantially reduced their use of the drug","volume":"99","author":"Morgan","year":"2004","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2015.04.022_bib0090","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1152\/physrev.00031.2008","article-title":"Role and therapeutic potential of VEGF in the nervous system","volume":"89","author":"Ruiz de Almodovar","year":"2009","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.drugalcdep.2015.04.022_bib0095","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1042\/CS20040370","article-title":"The vascular endothelial growth factor (VEGF)\/VEGF receptor system and its role under physiological and pathological conditions","volume":"109","author":"Takahashi","year":"2005","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.drugalcdep.2015.04.022_bib0100","doi-asserted-by":"crossref","first-page":"4647","DOI":"10.1073\/pnas.0610282104","article-title":"VEGF is an essential mediator of the neurogenic and behavioral actions of antidepressants","volume":"104","author":"Warner-Schmidt","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.drugalcdep.2015.04.022_bib0105","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1172\/JCI9369","article-title":"VEGF enhances angiogenesis and promotes blood\u2013brain barrier leakage in the ischemic brain","volume":"106","author":"Zhang","year":"2000","journal-title":"J. Clin. Invest."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871615002185?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871615002185?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,22]],"date-time":"2018-09-22T15:25:51Z","timestamp":1537629951000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871615002185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":21,"alternative-id":["S0376871615002185"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2015.04.022","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum level of vascular endothelial growth factor decreased in chronic ketamine abusers","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2015.04.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}